News search

    E.g., 23/11/2024
    E.g., 23/11/2024
    CNIC researchers
    Research
    30 Aug 2024
    Nature Medicine: CNIC scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

    Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine
    One of the girls who participte in the study.
    Research
    29 Jul 2024
    JACC Clinical Electrophysiology: The sooner the better: teaching healthy habits in elementary school reduces abdominal fat

    A study by the CNIC and Fundación SHE, supported by “la Caixa” Foundation, demonstrates that schools are a crucial environment for health promotion in children
    team photo
    About the CNIC
    11 Jun 2024
    Nucleic Acids Research: A CNIC team has created an innovative tool for the reliable and efficient study of gene function

    iSuRe-HadCre promises to become an essential tool for biomedical research using mouse models to modify and understand gene function
    About the CNIC
    7 Jun 2024
    Dr Fuster receives the Medal of the European Society for Clinical Investigation
    Dr. Fuster recibe el premio
    About the CNIC
    27 May 2024
    Dr Valentín Fuster receives the prestigious Lifetime Achievement Award of the World Heart Federation (WHF
    About the CNIC
    15 May 2024
    CNIC Co-Leads REACT, an international precision medicine project to transform cardiovascular prevention

    Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total
    Alexandra y Xoel
    About the CNIC
    11 May 2024
    CNIC receives a donation to investigate Hutchinson–Gilford progeria syndrome
    De izquierda a derecha: Immunofluorescencia en sección de corazón de pez cebra tras criolesion mostrando células proliferativas (blanco), cardiomiocitos (rojo) núcleos celulares (azul). Imagen de Microscopia electrónica mostrando mitocondrias. Gel Blue Native mostrando bandas correspondientes a supercomplejos formados por CIII (rojo) y CIV (verde).
    Research
    6 May 2024
    Development Cell: A CNIC study reveals the key role of mitochondrial proteins in cardiac regeneration

    Scientists at the CNIC, CIBER, and University of Berne identify the fundamental role of a family of proteins in an essential process for cellular energy production
    María Jesús Andrés, Carla Espinós (detrás), Rosa M Nevado (delante, al lado de MJA), Miguel de la Fuente, Rosa Carmona, Ana Barettino, Vicente Andrés, Pilar Gonzalo e Ignacio Benedicto.
    Research
    19 Apr 2024
    PNAS: CNIC scientists identify the key cell type for strategies to prevent atherosclerosis in progeria syndrome

    The elimination of progerin from vascular smooth muscle cells, but not from endothelial cells, prevents the atherosclerosis associated with Hutchinson-Gilford progeria syndrome (HGPS)
    RM cardiaca de un paciente con miocardiopatía dilatada (izquierda) y de un individuo sin cardiopatía (derecha). En el paciente con miocardiopatía dilatada el tamaño del corazón esta incrementado y su capacidad de bombeo está disminuida.
    Research
    19 Apr 2024
    JACC: A new Spanish study provides the first stratification of the risk of developing dilated cardiomyopathy among symptom-free genetic carriers

    The results, published in JACC, suggest that these factors could be used to predict the risk of developing dilated cardiomyopathy and adapt strategies for patient care and disease detection in genetic carriers of the disease